Navigation Links
Prolong's Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran
Date:12/15/2011

SOUTH PLAINFIELD, N.J., Dec. 15, 2011 /PRNewswire/ -- Prolong Pharmaceuticals today announced that Tom Flachmeyer has joined Prolong to spearhead the firms' engineering and facilities planning function for it oxygen therapeutic product SANGUINATE™.   Having previously directed the construction of the world's largest biotech facility to date, Wyeth's Grange Castle facility in Dublin, Ireland, Flachmeyer is charged with expanding Prolong's current cGMP production facility to support worldwide clinical development in sickle cell patients.

Tom brings an extensive background in managing technical organizations, strategic / capital planning and capital project execution and has a proven track record of executing technically complex projects. Formerly a Director of Project Management at Parsons, Life Sciences Group, Tom has held senior management positions in Engineering at Wyeth, Warner-Lambert (now Pfizer) and Foster Wheeler.  At Schering Plough he spent 5 years in Ireland and 3 years in Singapore executing large scale capital projects that delivered critical capabilities to the supply chain.

"Tom's international experience in designing high quality, large scale bio-manufacturing facilities to FDA approved status, is unparalleled in the industry," said Glenn Kazo, Prolong's President. "As lead project manager for several multinational engineering firms, and with direct experience as a bio-pharma company executive, Tom is ideally suited to drive our expansion." 

About Prolong Pharmaceuticals
Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing biopharmaceutical products targeting the treatment of anemia resulting from an oxygen deficiency. First founded in 2002 as a research company Prolong is focused on sickle cell anemia, diabetic ischemia, and several trauma indications. The company's senior management team includes inventors of the most successful drug delivery technology in pharmaceutical history, PEGylation, now responsible for more than $30 billion in drug sales worldwide. For more information visit: www.prolongpharmaceuticals.com.

 


'/>"/>
SOURCE Prolong Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
2. Tumor-Targeted Rexin-G Prolongs Survival in Gemcitabine-Resistant Metastatic Pancreas Cancer in Advanced Phase I and II Studies (ASCO 2010)
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Ion Channel Targets, Booth 5
5. Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM)
6. New carbon material shows promise of storing large quantities of renewable electrical energy
7. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
8. SAFC Pharma Completes Large-Scale API Manufacturing Expansion in Ireland
9. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest
10. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
11. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... , ... Stratevi, a boutique firm that partners with healthcare companies to creatively ... office in downtown Boston at 745 Atlantic Ave. , “We are seeing that ... on the value they provide, not just to patients, but also payers. Having a ...
(Date:5/21/2017)... ANGELES, CA (PRWEB) , ... May 19, 2017 ... ... the annual meeting and educational conference of the American Association of Bioanalysts (AAB) ... the Galleria Hotel in Houston. The conference reinforces AAB’s commitment to excellence in ...
(Date:5/19/2017)... ... May 19, 2017 , ... The University City Science ... technologies ripe for commercialization, and who are affiliated with the 21 partner academic ... proposals. QED, now in its tenth round, is the first multi-institutional proof-of-concept program ...
(Date:5/18/2017)... ... ... Clinical Supplies Management (“CSM”), a Great Point Partners II (“GPP”) portfolio company, today announced ... in size over the past six months with the acquisition of businesses in Belgium ... as Chief Financial Officer. Roger has over 25 years of experience in finance ...
Breaking Biology Technology:
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/16/2017)... Germany , March 16, 2017 CeBIT 2017 - Against identity ... Continue Reading ... Used combined in one project, multi-biometric solutions provide ... Used ... Systems) ...
Breaking Biology News(10 mins):